Trial intelligence / Profile preview

Formoterol MDI Phase 2 Dose-Finding Study in Adult Bronchial Asthma

jRCT2080220645Phase 2

Sponsor
Kyorin Pharmaceutical
Start
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in asthma comparing Formoterol MDI with Placebo MDI (2 arms).

02

Drugs

formoterol
03

Conditions

asthma

Beyond the preview

Go deeper on jRCT2080220645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call